N-of-One Announces Agreement with Foundation Medicine to Provide the First Patient-Specific Genomic Diagnostic …

WALTHAM, Mass.–(BUSINESS WIRE)–

N-of-One, Inc., provider of Diagnostic Strategy Roadmaps and Treatment Strategy Roadmaps for personalized cancer care, announced today that the company has entered into a strategic collaboration with Foundation Medicine, Inc. to support the development of its fully informative molecular cancer profiles that can be used to guide individualized patient treatment strategies.

Foundation Medicine will use its state-of-the-art genomic sequencing and analytic capabilities on patient tumor samples to detect and analyze molecular alterations in hundreds of cancer-related genes to potentially identify biological markers that may be driving the onset, growth, and spread of an individuals cancer. N-of-One will apply its PrecisionWorks knowledge integration platform for personalized medicine to assist in the transformation of cancer-relevant genomic alteration data identified by Foundation Medicine into clinically relevant information by linking each molecular variation with up-to-date information about relevant targeted therapies and clinical trials that may be effective against the individuals tumor. Foundation Medicine provides its reports to oncologists to help them determine appropriate treatment strategies tailored to each patient based on their specific genomic profile.

This collaboration represents another important step toward transforming next-generation sequencing into a decision-making tool that empowers oncologists to act rapidly and decisively in providing precision treatment strategies for their patients, said Jennifer Levin Carter, MD, Founder and President of N-of-One. We are delighted to work with Foundation Medicine to convert comprehensive cancer-associated molecular data from its market-leading test into customized reports that will help physicians optimize treatment strategies and improve patient outcomes.

N-of-One is a leader in the curation of molecular information, said Kevin Krenitsky, MD, COO of Foundation Medicine. N-of-One has developed a knowledge integration platform that will help us translate genomic alteration data into information that can be provided to clinicians to help them understand and act upon the genomic data we provide. We are excited to collaborate with N-of-One to provide our fully informative genomic profile to benefit patients.

About N-of-One

N-of-One is dedicated to helping oncologists identify optimal personalized diagnostic and treatment strategies for each individual patienteach n of one. Powered by our proprietary PrecisionWorks knowledge integration platform, the N-of-One team develops roadmaps that drive highly informed clinical decision-making by linking data about the molecular variations in each patients cancer cells with leading-edge knowledge, diagnostics, treatments, and technologies relevant to the tumor type. PrecisionWorks also powers solutions that address the unique logistical and procedural challenges of delivering personalized cancer care by streamlining coordination among health care providers, diagnostic companies, payers, drug and technology innovators, and patients. N-of-One works with physicians and therefore does not providemedical advice nor promote any product orservice. For more information, please visit www.n-of-one.com.

About Foundation Medicine

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patients unique cancer. The company has developed a fully informative genomic profile to identify a patients individual molecular alterations and match them with relevant targeted therapies and clinical trials. Foundation Medicines molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit the companys website www.foundationmedicine.com.

Read the original here:

(1) N-of-One Announces Agreement with Foundation Medicine to Provide the First Patient-Specific Genomic Diagnostic …
URL: http://finance.yahoo.com/news/n-one-announces-agreement-foundation-130000713.html;_ylt=A2KJjagv_sdPK1MA4gX_wgt.



Incoming Post Search Feeds:
nibiru
ison nibiru
petru aurelian simionescu 2013
Modern marvels regenerative medicine
Dr biochemistry gmail edu
futurists physical therapy
nasa nibiru 10 11 2013
NASA comet ison update
ppsspp monster hunter freedom unite tablet
techno fruhstuck correspondence heart beat

Related Post

Comments are closed.